These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20060848)

  • 1. Cadmium down-regulation of kidney Sp1 binding to mouse SGLT1 and SGLT2 gene promoters: possible reaction of cadmium with the zinc finger domain of Sp1.
    Kothinti RK; Blodgett AB; Petering DH; Tabatabai NM
    Toxicol Appl Pharmacol; 2010 May; 244(3):254-62. PubMed ID: 20060848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effect of cadmium on binding of transcription factor Sp1 to the GC-rich regions of the mouse sodium-glucose cotransporter 1, SGLT1, promoter.
    Tabatabai NM; Blumenthal SS; Petering DH
    Toxicology; 2005 Feb; 207(3):369-82. PubMed ID: 15664265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc finger transcription factor Zn3-Sp1 reactions with Cd2+.
    Kothinti R; Blodgett A; Tabatabai NM; Petering DH
    Chem Res Toxicol; 2010 Feb; 23(2):405-12. PubMed ID: 20073493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes.
    Solini A; Rossi C; Mazzanti CM; Proietti A; Koepsell H; Ferrannini E
    Diabetes Obes Metab; 2017 Sep; 19(9):1289-1294. PubMed ID: 28419670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium.
    Tabatabai NM; Blumenthal SS; Lewand DL; Petering DH
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):163-73. PubMed ID: 11749115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadmium decreases SGLT1 messenger RNA in mouse kidney cells.
    Blumenthal SS; Ren L; Lewand DL; Krezoski SK; Petering DH
    Toxicol Appl Pharmacol; 1998 Mar; 149(1):49-54. PubMed ID: 9512726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2.
    Kanwal A; Singh SP; Grover P; Banerjee SK
    Anal Biochem; 2012 Oct; 429(1):70-5. PubMed ID: 22796500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel frame-shift mutation in Slc5a2 encoding SGLT2 in a strain of senescence-accelerated mouse SAMP10.
    Unno K; Yamamoto H; Toda M; Hagiwara S; Iguchi K; Hoshino M; Takabayashi F; Hasegawa-Ishii S; Shimada A; Hosokawa M; Higuchi K; Mori M
    Biochem Biophys Res Commun; 2014 Nov; 454(1):89-94. PubMed ID: 25450362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse kidney expresses mRNA of four highly related sodium-glucose cotransporters: regulation by cadmium.
    Tabatabai NM; Blumenthal SS; Lewand DL; Petering DH
    Kidney Int; 2003 Oct; 64(4):1320-30. PubMed ID: 12969150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
    Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the zinc(II) ions in the structure of the three-finger DNA binding domain of the Sp1 transcription factor.
    Kuwahara J; Coleman JE
    Biochemistry; 1990 Sep; 29(37):8627-31. PubMed ID: 2271546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glucose transporters in duodenal mucosa of patients with type 1 diabetes.
    Bolla AM; Butera E; Pellegrini S; Caretto A; Bonfanti R; Zuppardo RA; Barera G; Cavestro GM; Sordi V; Bosi E
    Acta Diabetol; 2020 Nov; 57(11):1367-1373. PubMed ID: 32617672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of renal glucose reabsorption. Focus on "Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2".
    Vallon V
    Am J Physiol Cell Physiol; 2011 Jan; 300(1):C6-8. PubMed ID: 21048164
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved glycemic control in mice lacking Sglt1 and Sglt2.
    Powell DR; DaCosta CM; Gay J; Ding ZM; Smith M; Greer J; Doree D; Jeter-Jones S; Mseeh F; Rodriguez LA; Harris A; Buhring L; Platt KA; Vogel P; Brommage R; Shadoan MK; Sands AT; Zambrowicz B
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E117-30. PubMed ID: 23149623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
    Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
    Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor-1α (HIF-1α) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxia.
    Zapata-Morales JR; Galicia-Cruz OG; Franco M; Martinez Y Morales F
    J Biol Chem; 2014 Jan; 289(1):346-57. PubMed ID: 24196951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells.
    Solini A; Sebastiani G; Nigi L; Santini E; Rossi C; Dotta F
    Diabetes Metab; 2017 Dec; 43(6):512-520. PubMed ID: 28499695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG.
    Chang HC; Yang SF; Huang CC; Lin TS; Liang PH; Lin CJ; Hsu LC
    Mol Biosyst; 2013 Aug; 9(8):2010-20. PubMed ID: 23657801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadmium treatment suppresses DNA polymerase δ catalytic subunit gene expression by acting on the p53 and Sp1 regulatory axis.
    Antoniali G; Marcuzzi F; Casarano E; Tell G
    DNA Repair (Amst); 2015 Nov; 35():90-105. PubMed ID: 26519823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of SGLT1 and SGLT2 inhibitors.
    Rieg T; Vallon V
    Diabetologia; 2018 Oct; 61(10):2079-2086. PubMed ID: 30132033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.